Innovation
Overview
From global research discoveries to clinical breakthroughs – our vision is to become the most influential life sciences company for researchers
We are audacious in our approach to innovation
Employing the latest innovations is enabling our in-house new product development and manufacturing to grow at scale. When combined with our commercialization prowess and round-the-clock delivery, scientists are ensured rapid access to the newest and best proteomic research tools available globally.
With application across discovery research, diagnostics and therapeutic development, our products are accelerating the pace of life science research and improving the efficiency of experimental and diagnostic workflows.
Fueling the engine of life science research
Creating high-performance antibodies
Antibodies are proteins made by the body when exposed to unknown foreign substances, such as viruses. They are recognizable by their distinctive Y-shape and each antibody binds to a very specific part of the foreign substance, known as an antigen.
Developing a high-performance antibody with the desired features, such as specificity (the ability of an antibody to bind only to its target protein) and affinity (the strength with which an antibody binds to its target protein) and consistency, is challenging. To do this efficiently at scale requires extensive protein and cell-engineering skills and know-how.
We are generating antibodies directed against molecules of great interest to scientists for use in research, clinical diagnostic applications and therapeutics by using our proprietary technologies and expertise to improve upon this natural biological process.
VISIT OUR REGIONAL WEBSITES
Browse our latest products and services
Registered Office:
Discovery Drive, Cambridge
Biomedical Campus,
Cambridge, CB2 0AX, UK
+44 (0) 1223 696 000
VIEW PRODUCTS
© Abcam Limited. all rights reserved.
Abcam Limited is incorporated in England and Wales, its main country of operation in the UK. Use of this website is subject to our Terms and Conditions of use and our Privacy Policy. Share price and news information on this site is updated dynamically from external data feeds.
